Sartar appoints Dr. Maria Lahtinen as the new CDO

More great news before Christmas! We are happy to announce the appointment of Dr. Maria Lahtinen as the Chief Development Officer. Dr. Lahtinen has diligently served as the company’s Quality Director for the past year. The company’s CEO, Dr. Maksimow, expressed his excitement, stating, “I am thrilled to have Maria as our CDO, especially as we progress SAR003, our precision medicine, into the clinical phase. I’ve had the pleasure of working with Maria for several years and admire her profound expertise and pragmatic, friendly approach to all aspects of life.”

Dr. Lahtinen comments her new role: “I am exited about this opportunity. In the Chief Development Officer role I can seamlessly integrate all my education and experience in drug development, analytics, CMC, vendor cooperation, quality and compliance. This intersection of skills enables me to contribute effectively to the multifaceted responsibilities inherent in the position. To do my best for patients with high unmet medical needs. I am grateful to the Sartar team for the opportunity and trust received. I try to be worth it.”